122 related articles for article (PubMed ID: 7790717)
1. Cytolytic hepatitis with a venotonic drug.
Sgro C; Taque R; Zoll A; Hillon P
J Hepatol; 1995 Feb; 22(2):251. PubMed ID: 7790717
[No Abstract] [Full Text] [Related]
2. [Cirkan-induced chronic diarrhea].
Maechel H
Gastroenterol Clin Biol; 1992; 16(4):373. PubMed ID: 1397865
[No Abstract] [Full Text] [Related]
3. [Clinical study of the efficacy of Cirkan in phlebology].
Elbaz C
Phlebologie; 1980; 33(2):379-90. PubMed ID: 7005912
[No Abstract] [Full Text] [Related]
4. [Lymphocytic colitis in a women with Biermer's disease treated with Cirkan].
Rassiat E; Michiels C; Piard F; Faivre J
Presse Med; 2001 May 26-Jun 2; 30(19):970. PubMed ID: 11433731
[No Abstract] [Full Text] [Related]
5. Changes on venous diameter and leg perimeter with different clinical treatments for moderate chronic venous disease: evaluation using Duplex scanning and perimeter measurements.
Porto CL; Milhomens AL; Pires CE; Xavier SS; Sicuro F; Bottino DA; Bouskela E
Int Angiol; 2009 Jun; 28(3):222-31. PubMed ID: 19506542
[TBL] [Abstract][Full Text] [Related]
6. Effect of a venotonic agent on the main arteries and veins during a 5 day HDT.
Roumy J; Herault S; Tobal N; Besnard S; Arbeille P
Acta Astronaut; 2001; 49(3-10):161-6. PubMed ID: 11669105
[TBL] [Abstract][Full Text] [Related]
7. [The anti-edematous effect of an association of proteolytic enzymes, flavonoids, sterolic heteroside of Ruscus aculeatus and ascorbic acid (author's transl)].
Tarayre JP; Lauressergues H
Ann Pharm Fr; 1979; 37(5-6):191-8. PubMed ID: 396842
[No Abstract] [Full Text] [Related]
8. [Effects of a phlebotonic agent].
Thebault JJ
Fortschr Med; 1983 Jul; 101(25):1206-12. PubMed ID: 6350133
[No Abstract] [Full Text] [Related]
9. Advantages of a combination of proteolytic enzymes, flavonoids and ascorbic acid in comparison with non-steroid anti-inflammatory agents.
Tarayre JP; Lauressergues H
Arzneimittelforschung; 1977; 27(6):1144-9. PubMed ID: 578429
[TBL] [Abstract][Full Text] [Related]
10. Use of microcirculatory parameters to evaluate clinical treatments of chronic venous disorder (CVD).
Lascasas-Porto CL; Milhomens AL; Virgini-Magalhães CE; Fernandes FF; Sicuro FL; Bouskela E
Microvasc Res; 2008 May; 76(1):66-72. PubMed ID: 18423497
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a drug combination on venous capacity].
Rudofsky G; Nobbe F
Fortschr Med; 1982 Jul; 100(25):1217-20. PubMed ID: 7106687
[TBL] [Abstract][Full Text] [Related]
12. [Tolerance of Ercevit fort].
Chevat H; Durocher AM; Frigard B; Graux P
Lille Med; 1979 Mar; 24(3):245-9. PubMed ID: 491831
[No Abstract] [Full Text] [Related]
13. Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease.
Allaert FA
Int Angiol; 2016 Apr; 35(2):111-6. PubMed ID: 26928296
[TBL] [Abstract][Full Text] [Related]
14. [Wobe-Mugos: a proteolytic enzyme combination for tumor therapy. Documentation No. 7].
Schweiz Rundsch Med Prax; 1987 Dec; 76(51):1430-2. PubMed ID: 3326110
[No Abstract] [Full Text] [Related]
15. Clinical studies on the use of parenteral trypsin and chymotrypsin in peripheral vascular disease.
KRYLE LS; CALVELLI E; BONHAM DT; KUPPERMAN HS
Angiology; 1956 Jun; 7(3):287-91. PubMed ID: 13327313
[No Abstract] [Full Text] [Related]
16. The treatment of chronic venous disorder of the leg.
Allen S
Practitioner; 1970 Aug; 205(226):221-4. PubMed ID: 5480515
[No Abstract] [Full Text] [Related]
17. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
Tumino G; Berni A; Tromba L; Marignetti L
Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
[No Abstract] [Full Text] [Related]
18. [Treatment of varices of the lower extremities with a new drug combination: hemotrypsin].
Grosso F; Vetrò A
Atti Accad Med Lomb; 1975; 30(1-3):161-4. PubMed ID: 1234845
[No Abstract] [Full Text] [Related]
19. [Therapeutic trials of a trypsin-alpha-chymotrypsin combination in edema of venous origin and hydrolipopexia].
LINQUETTE M
Lille Med; 1963; 8():569-73. PubMed ID: 13930864
[No Abstract] [Full Text] [Related]
20. Allergy to chymotrypsin.
ALADJEM F; MACLAREN WR
J Allergy; 1957 Jan; 28(1):89-90. PubMed ID: 13398245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
